Veradermics, Inc. (MANE)
103.52
+5.06
(+5.14%)
USD |
NYSE |
Aug 25, 13:32
Veradermics Net Income (Quarterly) : -23.50M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.50M |
| March 31, 2026 | -27.23M |
| December 31, 2025 | -21.85M |
| Date | Value |
|---|---|
| June 30, 2025 | -15.64M |
| March 31, 2025 | -12.40M |
| December 31, 2024 | -5.66M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.095B |
| EyePoint, Inc. | -94.47M |
| Elanco Animal Health, Inc. | 54.00M |
| Tarsus Pharmaceuticals, Inc. | -18.55M |
| Amylyx Pharmaceuticals, Inc. | -43.42M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 23.50M |
| EPS Diluted (Quarterly) | -0.5625 |
| Enterprise Value | 3.294B |
| Earnings Yield | -2.52% |
| Normalized Earnings Yield | -2.516 |